Cystatin C and mortality risk in the elderly

The health, aging, and body composition study

Michael G. Shlipak, Christina L.Wassel Fyr, Glenn M. Chertow, Tamara B. Harris, Stephen B. Kritchevsky, Frances Tylavsky, Suzanne Satterfield, Steven R. Cummings, Anne B. Newman, Linda F. Fried

Research output: Contribution to journalArticle

157 Citations (Scopus)

Abstract

Kidney dysfunction is known to decrease life expectancy in the elderly. Cystatin C is a novel biomarker of kidney function that may have prognostic utility in older adults. The association of cystatin C with mortality was evaluated in a biracial cohort of black and white ambulatory elderly and compared with that of serum creatinine concentrations. The Health, Aging and Body Composition study is a cohort of well-functioning elderly that was designed to evaluate longitudinal changes in weight, body composition, and function. A total of 3075 participants who were aged 70 to 79 yr and had no disability were recruited at sites in Memphis, TN, and Pittsburgh, PA, between April 1997 and June 1998 with a follow-up of 6 yr. At entry, the mean cystatin C was 1.05 mg/L and the mean creatinine was 1.06 mg/dl. After 6 yr of follow-up, 557 participants had died. The mortality rates in each ascending cystatin C quintile were 1.7, 2.7, 2.9, 3.1, and 5.4%/yr. After adjustment for demographic risk factors, comorbid health conditions, and inflammatory biomarkers (C-reactive protein, IL-6. and TNF-α), each quintile of cystatin C was significantly associated with increased mortality risk compared with the lowest: Hazard ratios (HR; 95% confidence intervals) quintile 1, -1.0 (referent); quintile 2, -1.74 (1.21 to 2.50); quintile 3, -1.51 (1.05 to 2.18); quintile 4, -1.49 (1.04 to 2.13); and quintile 5, -2.18 (1.53 to 3.10). These associations did not differ by gender or race. Results were consistent for cardiovascular and other-cause mortality, but not cancer mortality. Creatinine quintiles were not associated with mortality after multivariate adjustment (HR: 1.0 [referent], 1.00 [0.72 to 1.39], 0.95 [0.68 to 1.32], 1.11 [0.79 to 1.57], 1.16 [0.86 to 1.58]). Cystatin C is a strong, independent risk factor for mortality in the elderly. Future studies should investigate whether cystatin C has a role in clinical medicine.

Original languageEnglish (US)
Pages (from-to)254-261
Number of pages8
JournalJournal of the American Society of Nephrology
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Cystatin C
Body Composition
Mortality
Health
Creatinine
Biomarkers
Kidney
Clinical Medicine
Life Expectancy
C-Reactive Protein
Interleukin-6
Demography
Confidence Intervals
Weights and Measures
Serum

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

Shlipak, M. G., Fyr, C. L. W., Chertow, G. M., Harris, T. B., Kritchevsky, S. B., Tylavsky, F., ... Fried, L. F. (2006). Cystatin C and mortality risk in the elderly: The health, aging, and body composition study. Journal of the American Society of Nephrology, 17(1), 254-261. https://doi.org/10.1681/ASN.2005050545

Cystatin C and mortality risk in the elderly : The health, aging, and body composition study. / Shlipak, Michael G.; Fyr, Christina L.Wassel; Chertow, Glenn M.; Harris, Tamara B.; Kritchevsky, Stephen B.; Tylavsky, Frances; Satterfield, Suzanne; Cummings, Steven R.; Newman, Anne B.; Fried, Linda F.

In: Journal of the American Society of Nephrology, Vol. 17, No. 1, 01.01.2006, p. 254-261.

Research output: Contribution to journalArticle

Shlipak, MG, Fyr, CLW, Chertow, GM, Harris, TB, Kritchevsky, SB, Tylavsky, F, Satterfield, S, Cummings, SR, Newman, AB & Fried, LF 2006, 'Cystatin C and mortality risk in the elderly: The health, aging, and body composition study', Journal of the American Society of Nephrology, vol. 17, no. 1, pp. 254-261. https://doi.org/10.1681/ASN.2005050545
Shlipak, Michael G. ; Fyr, Christina L.Wassel ; Chertow, Glenn M. ; Harris, Tamara B. ; Kritchevsky, Stephen B. ; Tylavsky, Frances ; Satterfield, Suzanne ; Cummings, Steven R. ; Newman, Anne B. ; Fried, Linda F. / Cystatin C and mortality risk in the elderly : The health, aging, and body composition study. In: Journal of the American Society of Nephrology. 2006 ; Vol. 17, No. 1. pp. 254-261.
@article{9757a70ae59d4ca180d54b32c6bea249,
title = "Cystatin C and mortality risk in the elderly: The health, aging, and body composition study",
abstract = "Kidney dysfunction is known to decrease life expectancy in the elderly. Cystatin C is a novel biomarker of kidney function that may have prognostic utility in older adults. The association of cystatin C with mortality was evaluated in a biracial cohort of black and white ambulatory elderly and compared with that of serum creatinine concentrations. The Health, Aging and Body Composition study is a cohort of well-functioning elderly that was designed to evaluate longitudinal changes in weight, body composition, and function. A total of 3075 participants who were aged 70 to 79 yr and had no disability were recruited at sites in Memphis, TN, and Pittsburgh, PA, between April 1997 and June 1998 with a follow-up of 6 yr. At entry, the mean cystatin C was 1.05 mg/L and the mean creatinine was 1.06 mg/dl. After 6 yr of follow-up, 557 participants had died. The mortality rates in each ascending cystatin C quintile were 1.7, 2.7, 2.9, 3.1, and 5.4{\%}/yr. After adjustment for demographic risk factors, comorbid health conditions, and inflammatory biomarkers (C-reactive protein, IL-6. and TNF-α), each quintile of cystatin C was significantly associated with increased mortality risk compared with the lowest: Hazard ratios (HR; 95{\%} confidence intervals) quintile 1, -1.0 (referent); quintile 2, -1.74 (1.21 to 2.50); quintile 3, -1.51 (1.05 to 2.18); quintile 4, -1.49 (1.04 to 2.13); and quintile 5, -2.18 (1.53 to 3.10). These associations did not differ by gender or race. Results were consistent for cardiovascular and other-cause mortality, but not cancer mortality. Creatinine quintiles were not associated with mortality after multivariate adjustment (HR: 1.0 [referent], 1.00 [0.72 to 1.39], 0.95 [0.68 to 1.32], 1.11 [0.79 to 1.57], 1.16 [0.86 to 1.58]). Cystatin C is a strong, independent risk factor for mortality in the elderly. Future studies should investigate whether cystatin C has a role in clinical medicine.",
author = "Shlipak, {Michael G.} and Fyr, {Christina L.Wassel} and Chertow, {Glenn M.} and Harris, {Tamara B.} and Kritchevsky, {Stephen B.} and Frances Tylavsky and Suzanne Satterfield and Cummings, {Steven R.} and Newman, {Anne B.} and Fried, {Linda F.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1681/ASN.2005050545",
language = "English (US)",
volume = "17",
pages = "254--261",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "1",

}

TY - JOUR

T1 - Cystatin C and mortality risk in the elderly

T2 - The health, aging, and body composition study

AU - Shlipak, Michael G.

AU - Fyr, Christina L.Wassel

AU - Chertow, Glenn M.

AU - Harris, Tamara B.

AU - Kritchevsky, Stephen B.

AU - Tylavsky, Frances

AU - Satterfield, Suzanne

AU - Cummings, Steven R.

AU - Newman, Anne B.

AU - Fried, Linda F.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Kidney dysfunction is known to decrease life expectancy in the elderly. Cystatin C is a novel biomarker of kidney function that may have prognostic utility in older adults. The association of cystatin C with mortality was evaluated in a biracial cohort of black and white ambulatory elderly and compared with that of serum creatinine concentrations. The Health, Aging and Body Composition study is a cohort of well-functioning elderly that was designed to evaluate longitudinal changes in weight, body composition, and function. A total of 3075 participants who were aged 70 to 79 yr and had no disability were recruited at sites in Memphis, TN, and Pittsburgh, PA, between April 1997 and June 1998 with a follow-up of 6 yr. At entry, the mean cystatin C was 1.05 mg/L and the mean creatinine was 1.06 mg/dl. After 6 yr of follow-up, 557 participants had died. The mortality rates in each ascending cystatin C quintile were 1.7, 2.7, 2.9, 3.1, and 5.4%/yr. After adjustment for demographic risk factors, comorbid health conditions, and inflammatory biomarkers (C-reactive protein, IL-6. and TNF-α), each quintile of cystatin C was significantly associated with increased mortality risk compared with the lowest: Hazard ratios (HR; 95% confidence intervals) quintile 1, -1.0 (referent); quintile 2, -1.74 (1.21 to 2.50); quintile 3, -1.51 (1.05 to 2.18); quintile 4, -1.49 (1.04 to 2.13); and quintile 5, -2.18 (1.53 to 3.10). These associations did not differ by gender or race. Results were consistent for cardiovascular and other-cause mortality, but not cancer mortality. Creatinine quintiles were not associated with mortality after multivariate adjustment (HR: 1.0 [referent], 1.00 [0.72 to 1.39], 0.95 [0.68 to 1.32], 1.11 [0.79 to 1.57], 1.16 [0.86 to 1.58]). Cystatin C is a strong, independent risk factor for mortality in the elderly. Future studies should investigate whether cystatin C has a role in clinical medicine.

AB - Kidney dysfunction is known to decrease life expectancy in the elderly. Cystatin C is a novel biomarker of kidney function that may have prognostic utility in older adults. The association of cystatin C with mortality was evaluated in a biracial cohort of black and white ambulatory elderly and compared with that of serum creatinine concentrations. The Health, Aging and Body Composition study is a cohort of well-functioning elderly that was designed to evaluate longitudinal changes in weight, body composition, and function. A total of 3075 participants who were aged 70 to 79 yr and had no disability were recruited at sites in Memphis, TN, and Pittsburgh, PA, between April 1997 and June 1998 with a follow-up of 6 yr. At entry, the mean cystatin C was 1.05 mg/L and the mean creatinine was 1.06 mg/dl. After 6 yr of follow-up, 557 participants had died. The mortality rates in each ascending cystatin C quintile were 1.7, 2.7, 2.9, 3.1, and 5.4%/yr. After adjustment for demographic risk factors, comorbid health conditions, and inflammatory biomarkers (C-reactive protein, IL-6. and TNF-α), each quintile of cystatin C was significantly associated with increased mortality risk compared with the lowest: Hazard ratios (HR; 95% confidence intervals) quintile 1, -1.0 (referent); quintile 2, -1.74 (1.21 to 2.50); quintile 3, -1.51 (1.05 to 2.18); quintile 4, -1.49 (1.04 to 2.13); and quintile 5, -2.18 (1.53 to 3.10). These associations did not differ by gender or race. Results were consistent for cardiovascular and other-cause mortality, but not cancer mortality. Creatinine quintiles were not associated with mortality after multivariate adjustment (HR: 1.0 [referent], 1.00 [0.72 to 1.39], 0.95 [0.68 to 1.32], 1.11 [0.79 to 1.57], 1.16 [0.86 to 1.58]). Cystatin C is a strong, independent risk factor for mortality in the elderly. Future studies should investigate whether cystatin C has a role in clinical medicine.

UR - http://www.scopus.com/inward/record.url?scp=33645452545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645452545&partnerID=8YFLogxK

U2 - 10.1681/ASN.2005050545

DO - 10.1681/ASN.2005050545

M3 - Article

VL - 17

SP - 254

EP - 261

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 1

ER -